DBD Stock Analysis: Buy, Sell, or Hold?
DBD - Diebold Nixdorf, Incorporated
$83.09
0.21 (0.25%)
▲
5d:
+0.46%
30d:
+14.77%
90d:
+9.95%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When DBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: DBD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: DBD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$159.62
Based on 13.9% avg growth
INTRINSIC VALUE TODAY
$99.11
16.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DBD is currently trading at $83.09, which is considered slightly high relative to its 30-day fair value range of $74.42 to $83.87. The stock's valuation (Forward PE: 12.2) is in line with its historical norms (12.4). Remarkably, the market is currently pricing in an annual earnings decline of 0.5% over the next few years. This pessimistic expectation contrasts with the company's recent 815.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DBD is in a uptrend. The price is approaching resistance at $84.81. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DBD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (6th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $98.33 (+18.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DBD is in a uptrend. The price is approaching resistance at $84.81. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DBD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (6th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $98.33 (+18.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$74.42 -
$83.87
Company Quality Score
60/100
(HOLD)
Options IV Signal
6th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
78.8%
All Signals
- BULLISH: Options cheap (IV 6th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($98.33)
Trading Range Analysis
30-Day Trading Range
$74.42 -
$83.87
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$5.02
(6.0%)
Support & Resistance Levels
Support Level
$77.41
Resistance Level
$84.81
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.20
Wall Street Target
$98.33
(+18.6%)
Revenue Growth (YoY)
6.0%
Earnings Growth (YoY)
815.4%
Profit Margin
2.8%
Valuation Discount vs History
-0.5% cheaper
PE vs Historical
12.2 vs 12.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.5%
(market-implied from PE analysis)
1-Year Target
$82.47
(-1%)
2-Year Target
$82.05
(-1%)
3-Year Target
$81.64
(-2%)
3-Yr Target (if PE normalizes)
(PE: 12→12)
$82.98
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 23.7%)
$280.33
(+238%)
Base:
(SPY PE: 12.2, Growth: 23.7%)
$157.03
(+90%)
Bear:
(PE: 10.4, Growth: 23.7%)
$133.47
(+61%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 28.90 | Current EPS (TTM): $2.90
Bull Case
$184.38
(+123%)
Analyst growth 100.0%, PE expands to 31.8
Base Case
$167.62
(+102%)
Market implied 100.0%, PE stable at 28.9
Bear Case
$56.99
(-31%)
Severe decline -20.0%, PE contracts to 24.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.2 to 12.4
Stabilization Target:
$84.24
(+1.6%)
PE Expansion Potential:
+1.6%
Share & Embed Analysis
Last updated: June 23, 2026 2:45 PM ET
Data refreshes hourly during market hours. Next update: 3:45 PM
Data refreshes hourly during market hours. Next update: 3:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DBD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Millstreet Capital Manag…
SELL
60833 shares
2026-04-16
Millstreet Capital Manag…
SELL
51472 shares
2026-04-15
Millstreet Capital Manag…
SELL
399929 shares
2026-04-08
Top Rated Software - Application Stocks
Top-rated stocks in Software - Application by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SNOW
Snowflake Inc. |
STRONG BUY
51 analysts |
$292 | 57 HOLD |
|
HUBS
HubSpot Inc |
STRONG BUY
36 analysts |
$280 | 53 HOLD |
|
NOW
ServiceNow Inc |
STRONG BUY
47 analysts |
$142 | 51 HOLD |
|
INTU
Intuit Inc |
STRONG BUY
34 analysts |
$488 | 50 HOLD |
|
DT
Dynatrace Holdings LLC |
STRONG BUY
34 analysts |
$45 | 54 HOLD |
Advanced DBD Option Strategies
Professional options setups generated by AI based on today's DBD price and gamma walls.
